Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

ClinicalTrials.gov ID: NCT00568633

Public ClinicalTrials.gov record NCT00568633. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A California Cooperative Clinical Study Comparing Allogeneic Hematopoietic Cell Transplantation Using Nonmyeloablative Host Conditioning With Total Lymphoid Irradiation and Anti-thymocyte Globulin Versus Best Standard of Care in Acute Myeloid Leukemia (AML) in First Complete Remission

Study identification

NCT ID
NCT00568633
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stanford University
Other
Enrollment
58 participants

Conditions and interventions

Interventions

  • Allogeneic HSCT Procedure
  • Anti-thymocyte globulin (ATG) Drug
  • Best standard care Drug
  • Cyclosporine (CSP) Drug
  • Methylprednisolone sodium succinate Drug
  • Mycophenolate mofetil (MMF) Drug
  • Total lymphoid irradiation (TLI) Radiation

Procedure · Drug · Radiation

Eligibility (public fields only)

Age range
50 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Dec 30, 2015
Completion
Dec 30, 2015
Last update posted
Sep 23, 2019

2007 – 2015

United States locations

U.S. sites
5
U.S. states
2
U.S. cities
5
Facility City State ZIP Site status
Kaiser Permanente Northern California Hayward California 94545
Cedars-Sinai Medical Center Los Angeles California 90048
Univeristy of California Davis Medical Center Sacramento California 95817
Stanford University School of Medicine Stanford California 94305
West Virginia University Hospital Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00568633, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2019 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00568633 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →